Please assess the completion status of the following clinical trial:

Trial Title: DHA Supplementation and Pregnancy Outcome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant 8-20 wks at enrollment~* single fetus~* BMI \<40~Exclusion Criteria:~* diabetes (Type I, ii, GDM)~* hypertension (primary, PIH, preeclampsia/eclampsia)

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 36 Years
- Healthy Volunteers: t

Study Arms:
- DHA capsules (Type: EXPERIMENTAL): DHA capsules
- Placebo capsules (Type: PLACEBO_COMPARATOR): Placebo capsule

Based on this trial design, predict the completion outcome and termination type (if applicable).